1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Pediatric Cancer-Pipeline Insights, 2014

Pediatric Cancer-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Pediatric Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Pediatric Cancer. This report provides information on the therapeutic development based on the Pediatric Cancer dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Pediatric Cancer
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Pediatric Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Pediatric Cancer and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Pediatric Cancer
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Pediatric Cancer pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Pediatric Cancer-Pipeline Insights, 2014
Table of Contents
- Pediatric Cancer Overview
- Pediatric Cancer Pipeline Therapeutics
- Pediatric Cancer Therapeutics under Development by Companies
- Pediatric Cancer Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Pediatric Cancer Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Pediatric Cancer Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Pediatric Cancer Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Pediatric Cancer - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Pediatric Cancer - Discontinued Products
- Pediatric Cancer - Dormant Products
- Companies Involved in Therapeutics Development for Pediatric Cancer
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Pediatric Cancer, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Pediatric Cancer Assessment by Monotherapy Products
- Pediatric Cancer Assessment by Combination Products
- Pediatric Cancer Assessment by Route of Administration
- Pediatric Cancer Assessment by Stage and Route of Administration
- Pediatric Cancer Assessment by Molecule Type
- Pediatric Cancer Assessment by Stage and Molecule Type
- Pediatric Cancer Therapeutics - Discontinued Products
- Pediatric Cancer Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Pediatric Cancer, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Pediatric Cancer Assessment by Monotherapy Products
- Pediatric Cancer Assessment by Combination Products
- Pediatric Cancer Assessment by Route of Administration
- Pediatric Cancer Assessment by Stage and Route of Administration
- Pediatric Cancer Assessment by Molecule Type
- Pediatric Cancer Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Oncology Devices - Medical Devices Pipeline Assessment, 2016

Oncology Devices - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Oncology Devices - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Oncology Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of ...

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides ...

 Pediatric Cancer-Pipeline Insights, 2017

Pediatric Cancer-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Pediatric Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Pediatric Cancer. The DelveInsight’sReport ...


Download Unlimited Documents from Trusted Public Sources

The future of the Specialty Hospital Industry in India

  • February 2017
    6 pages
  • Specialty Hospi...  

    Cancer  

    Patient Data Ma...  

  • India  

    Asia  

View report >

Hospital Industry in the UK

  • October 2016
    8 pages
  • Hospital  

    Cancer  

  • United Kingdom  

View report >

Hospital Industry in the UK

  • October 2016
    7 pages
  • Hospital  

    Cancer  

  • United Kingdom  

View report >

Related Market Segments :

Specialty Hospital

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.